
Search
Selected Filter
Filter Results
Displaying 471–480 of 504 news results
-
Jun 12, 2013
Patient Registries Help Advance Research for Rare Diseases
Many registries enable patients to collect and track information about their health, so they can take an active role in managing their care.
-
May 10, 2013
Grow Your Own: Harnessing Muller Glia for Retinal Regeneration
There’s hope for retinal regeneration for humans, thanks to Foundation-funded researcher Dr. Thomas Reh, who is investigating how to derive new photoreceptors from retinal cells called Muller glia.
-
May 7, 2013
Retinal Regeneration is Major Focus of NEI's Audacious Goal
The goal, “to regenerate the neurons and neural connections in the eye and visual system,” is exactly what people with retinal diseases need to save and restore their vision.
-
Apr 30, 2013
Researcher Revolutionized Fight Against Blindness and Cancer
A profile on Dr. Robert Langer, a medical researcher who has received dozens of awards, accolades and honorary degrees, including, recently, FFB’s Visionary Award.
-
Apr 17, 2013
A New Therapeutic Trick for Old Dogs
A New Therapeutic Trick for Old Dogs
-
Mar 29, 2013
DHA and EPA for Stargardt Disease — an Evolving Story
These healthy fats have exciting potential for treating a wide range of retinal degenerations and other health conditions.
-
Mar 15, 2013
Proving a Vision-Saving Treatment Works
The information gleaned from ProgSTAR will be of enormous value in designing future clinical trials for Stargardt disease treatments.
-
Mar 8, 2013
Staying Alive: Saving Retinal Cells to Preserve Vision
Sometimes, saving vision simply comes down to keeping retinal cells alive, or at least slowing their degeneration.
-
Feb 18, 2013
More good news about treatments and technological advances for restoring vision for people with retinal diseases.
-
Feb 14, 2013
How an FDA-Approved Retinal Prosthesis Came To Be
The Argus II Retinal Prosthesis System was recently granted market approval by the U.S. Food and Drug Administration (FDA), which marks a significant milestone in the development of a therapy that has spanned more than 20 years.